On May 12th, Ardelyx Inc (NASDAQ:ARDX) shares plummeted 39%, quite a stark drop. The cause: a disappointing read-out of the first of two …
Ardelyx Inc (NASDAQ:ARDX) investors are having a rough day after the drug maker reported topline results from its T3MPO-1 trial, the first of …
